Aerska is a biotechnology company that is creating RNA medications to treat, delay, and prevent brain disorders.
Aerska has raised $39.0M in total funding. The most recent round was Series A. The last funding was announced in February 2026.
Aerska's investors include Speedinvest, BlueYard Capital, BACKED VC, Ada Ventures, PsyMed Ventures.
Aerska is headquartered in Dublin, Ireland.
Aerska is a biotechnology company that is creating RNA medications to treat, delay, and prevent brain disorders.
Aerska is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aerska — Funding & Investors." VCBacked, February 9, 2026, https://www.vcbacked.co/company/aerska. Accessed July 19, 2026.
VCBacked. (2026). Aerska — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/aerska
{{cite web |title=Aerska — Funding & Investors |url=https://www.vcbacked.co/company/aerska |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated